AI for Pharma & Healthcare 2025

Industry Updates

Weight Watchers To Present At The Citi 2015...

Weight Watchers International, Inc. (NYSE: WTW) today announced that Nicholas Hotchkin, Chief Financial Officer, will present at the Citi 2015 Global Consumer Conference in New...

Actavis Confirms Appeals Court Ruling Requiring Continued Distribution...

Actavis plc (NYSE: ACT) today confirmed that a panel of the U.S. Court of Appeals for the Second Circuit has issued a ruling upholding a...

Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO...

The U.S. Food and Drug Administration's (FDA) recent approval of Zarxio (filgrastim-sndz) -- the first biosimilar product approved in the United States -- points toward...

Nevro Announces First Commercial Procedure of HF10â„¢ Therapy...

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the...

Pro-Ballers Lend Support for DreamCourt at Boys &...

Fourteen pro-basketball legends and NFL players wielded their star power to raise $26,000 for construction of a DreamCourt™ at the Holthouse Boys & Girls Club....

WuXi Launches e-Commerce Platform for Chemistry Products

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations...

SQI Diagnostics Reports Second Quarter Financial Results

SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF),a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »